Cubist Systematic Strategies, LLC Monte Rosa Therapeutics, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 92,818 shares of GLUE stock, worth $629,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,818Holding current value
$629,306% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding GLUE
# of Institutions
102Shares Held
49.1MCall Options Held
285KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$52.2 Million3.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.12MShares$48.3 Million0.01% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$38.3 Million58.01% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$33.3 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.35MShares$29.5 Million0.44% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $317M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...